DABIGATRAN Sandoz caps 150 mg 180 pce

7680686580046 CH-68658 B01AE07 06.03.0.
DABIGATRAN Sandoz caps 150 mg 180 pce
DABIGATRAN Sandoz caps 150 mg 180 pce
DABIGATRAN Sandoz caps 150 mg 180 pce
1 / 3
google

Details

Product number
6865802
CPT
-
Packaging group
180
Unit
Kapsel(n)
Composition
dabigatranum etexilatum 150 mg ut dabigatrani etexilati mesilas, acidum tartaricum, hypromellosum, talcum, hydroxypropylcellulosum, carmellosum natricum conexum, magnesii stearas, Kapselhülle: hypromellosum, E 171, Drucktinte: lacca, propylenglycolum, E 172 (nigrum), kalii hydroxidum, pro capsula corresp. natrium 0.9 mg.

Articles (1)

Dabigatran Sandoz 150 mg, Hartkapseln
Kapseln
180
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
05/08/2024
Professional SmPC
Français
05/08/2024
Professional SmPC
Italien
05/08/2024
Patient information leaflet
Allemand
31/07/2024
Patient information leaflet
Français
31/07/2024
Patient information leaflet
Italien
31/07/2024

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
0.9 MG Substance HBESI

Reimbursement information

Public price
CHF 150.10
Specialties list
Yes
Generic
Yes
SL addition date: 01/11/2023

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
68658
Drug name
Dabigatran Sandoz, Hartkapseln
Galenic form
KAHA
ATC Code
B01AE07
Authorization status
Z
Dispensation category
B
First authorization
07/06/2023
Authorization expiration date
06/06/2028
IT number
06.03.0.
Domain
Human medicine
Field of application
Prävention von Schlaganfall und systemischer Embolie bei erwachsenen Patienten mit nicht-valvulärem Vorhofflimmern. Behandlung tiefer Venenthrombosen und/oder Lungenembolien. Prävention der rezidivierenden tiefen Venenthrombose und/oder Lungenembolie.

Packaging details

Description (FR)
DABIGATRAN Sandoz caps 150 mg 180 pce
Description (DE)
DABIGATRAN Sandoz Kaps 150 mg 180 Stk
Market launch
07/06/2023
Narcotic (BTM)
No

Original drug

Pradaxa, Kapseln
GTIN: 7680613850150
CHF 71.50
View original

Other packaging sizes

DABIGATRAN Sandoz caps 110 mg 60 pce
60 KAP
GTIN: 7680686580015
View
DABIGATRAN Sandoz caps 110 mg 180 pce
180 KAP
GTIN: 7680686580022
View
DABIGATRAN Sandoz caps 150 mg 60 pce
60 KAP
GTIN: 7680686580039
View